Medical Directory™ Auxiliary 2024

FREE LISTINGS 484 Medical Directory | Brought to you by : Dotcom Africa (Pty) Ltd MEDICAL TECHNICIANS THE WAY TO CONNECT WITH THE MEDICAL INDUSTRY AND BEYOND NANOPARTICLES CREATE ‘MIRACLE’ TREATMENT FOR DEADLY BRAIN TUMORS The nanoparticle breakthrough delivers medication intravenously into the patient. These particles, which house the cancer cell-killing drug, are able to slip past the blood-brain barrier and target malignant tumors forming in the brain. long with a combination of radiation, the Michigan team says seven of eight mice given this treatment survived their cancers. More importantly, when those seven mice had a recurrence of glioblastoma, their immune systems prevented the cancer from growing back. Each mouse was able to do this without needing further treatments or radiation. “It’s still a bit of a miracle to us,” says co-senior author Joerg Lahann in a university release. “Where we would expect to see some levels of tumor growth, they just didn’t form when we rechallenged the mice. I’ve worked in this field for more than 10 years and have not seen anything like this.” Teaching the body how to beat cancer Researchers say infusing nanoparticles with cancer drugs not only delivered a lethal blow to the main brain tumor, but also helped the patient’s immune system to recog- nize and attack cancer cells. ANN ARBOR, Mich. — For scientists treating diseases in the brain, crossing the body’s natural barriers to this organ is the most difficult task to complete. Now, scientists at the University of Michigan say nanoparticles are allowing them to break through the nearly impenetrable blood-brain barrier. The achievement is giving cancer researchers the opportunity to deliver a new and game-changing drug to kill brain tumors. Glioblastoma is the most common and deadliest form of brain cancer in adults. Cases of the illness continue to rise in several countries. The average survival length for patients with glioblastoma is about 18 months. Less than five percent of patients live longer than five years after their diagnosis. By Chris Melore Click Here to Read More